Victoza® (liraglutide) is a prescription GLP-1 receptor agonist designed to help improve blood-sugar control in adults and certain pediatric patients with type 2 diabetes when used alongside diet and exercise. Its once-daily injection format offers a convenient option for patients whose healthcare professional has determined that liraglutide is appropriate for their treatment plan.
For people searching for Victoza weight loss, it is important to understand that Victoza is approved for the management of type 2 diabetes rather than specifically for chronic weight management. Liraglutide may affect appetite and body weight in some patients, but individual results vary and treatment should always be guided by a qualified healthcare professional.
Key Features & Benefits
- Active ingredient: Liraglutide, a GLP-1 receptor agonist.
- Once-daily administration: Designed for convenient daily use as prescribed.
- Type 2 diabetes support: Used alongside diet and exercise to improve glycemic control.
- Pre-filled injection pen: Provides a practical delivery format for prescribed doses.
- Personalized treatment: Your healthcare professional can determine whether Victoza is suitable for your individual needs.
Victoza carries important safety warnings and is not suitable for everyone, including people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Always read the prescribing information and use Victoza only as directed by your healthcare professional.



Reviews
There are no reviews yet.